Jiangsu Hengrui Medicine Co., Ltd.
600276
Kedudukan dalam Saham
#544
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Harga Saham
$6.89
Modal Pasaran
$43.94B
Perubahan (1 hari)
-2.91%
Perubahan (1 tahun)
-24.78%
Negara
CN
Perdagangan Jiangsu Hengrui Medicine Co., Ltd. (600276)
Kategori
Healthcare
Bilangan saham terbitan bagi Jiangsu Hengrui Medicine Co., Ltd. (600276)
Bilangan saham terbitan setakat October 2026: 0
Menurut laporan kewangan terkini dan harga saham Jiangsu Hengrui Medicine Co., Ltd., bilangan saham terbitan semasa ialah 0. Pada akhir October 2026, syarikat mempunyai 0 saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk Jiangsu Hengrui Medicine Co., Ltd. (600276) dari 2001 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2025 | 6.50B | 2.58% |
| 2024 | 6.34B | 0.15% |
| 2023 | 6.33B | -0.63% |
| 2022 | 6.37B | -0.21% |
| 2021 | 6.38B | 0.38% |
| 2020 | 6.36B | 0.31% |
| 2019 | 6.34B | -0.42% |
| 2018 | 6.36B | 1.14% |
| 2017 | 6.29B | -0.45% |
| 2016 | 6.32B | -0.18% |
| 2015 | 6.33B | 0.46% |
| 2014 | 6.30B | -0.11% |
| 2013 | 6.31B | 0.29% |
| 2012 | 6.29B | -0.01% |
| 2011 | 6.29B | 0.36% |
| 2010 | 6.27B | 0.00% |
| 2009 | 6.27B | 0.26% |
| 2008 | 6.25B | -0.01% |
| 2007 | 6.25B | 0.00% |
| 2006 | 6.25B | 87.25% |
| 2005 | 3.34B | 0.00% |
| 2004 | 3.34B | 0.00% |
| 2003 | 3.34B | 0.00% |
| 2002 | 3.34B | 0.00% |
| 2001 | 3.34B | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 2.40B | - |
IN
|
